Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$2.92M Sell
235,081
-134,510
-36% -$1.69M 0.44% 20
2025
Q1
$5.63M Buy
369,591
+89,400
+32% +$1.34M 1.01% 16
2024
Q4
$4.09M Sell
280,191
-50,418
-15% -$787K 0.67% 18
2024
Q3
$5.28M Hold
330,609
0.88% 15
2024
Q2
$6.28M Sell
330,609
-49,180
-13% -$922K 1.17% 12
2024
Q1
$7.41M Buy
+379,789
New +$7.07M 2.02% 9

Other funds holding NOV

Belmont Capital's NOV Position: Q2 2025 in Review

Belmont Capital reduced its NOV (NOV) stake by 36% in Q2 2025, selling an estimated $1.69M and leaving 235,081 shares worth $2.92M. The position accounts for 0.44% of the portfolio, ranked #20.

Belmont Capital first reported a position in NOV in Q1 2024 and has held it in 6 quarters since. The position peaked at $7.41M in Q1 2024. 431 funds tracked by Wall St. Rank hold NOV as of Q2 2025.

  • Belmont Capital held 235,081 shares of NOV worth $2.92M as of Q2 2025.
  • Belmont Capital sold 134,510 NOV shares in Q2 2025, an estimated $1.69M.
  • NOV made up 0.44% of Belmont Capital's portfolio in Q2 2025, its #20 holding.
  • Belmont Capital first reported a position in NOV in Q1 2024 and has held it in 6 quarters since.
  • Belmont Capital's NOV position peaked at $7.41M in Q1 2024.
  • 431 funds tracked by Wall St. Rank held NOV as of Q2 2025.

Based on Belmont Capital's 13F filing for Q2 2025, filed 12 Aug 2025.